Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington's disease

By Ryu J.K.   Kim S.U.   McLarnon J.G.  

Experimental Neurology, Vol. 183, Iss. 2, 2003-10 ,pp. : 700-704

Elsevier

Access to resources Recommend Favorite

Striatal Transplantation in a Transgenic Mouse Model of Huntington's Disease

By Dunnett S.B.   Carter R.J.   Watts C.   Torres E.M.   Mahal A.   Mangiarini L.   Bates G.   Morton A.J.  

Experimental Neurology, Vol. 154, Iss. 1, 1998-11 ,pp. : 31-40

Elsevier

Access to resources Recommend Favorite

Neuroprotective Effect of a CNTF-Expressing Lentiviral Vector in the Quinolinic Acid Rat Model of Huntington's Disease

By de Almeida L.P.   Zala D.   Aebischer P.   Déglon N.  

Neurobiology of Disease, Vol. 8, Iss. 3, 2001-06 ,pp. : 433-446

Academic Press

Access to resources Recommend Favorite

Quinolinic Acid Released from Polymeric Brain Implants Causes Behavioral and Neuroanatomical Alterations in a Rodent Model of Huntington's Disease

By Haik K.L.   Shear D.A.   Schroeder U.   Sabel B.A.   Dunbar G.L.  

Experimental Neurology, Vol. 163, Iss. 2, 2000-06 ,pp. : 430-439

Elsevier

Access to resources Recommend Favorite

The IGF-I Amino-Terminal Tripeptide Glycine-Proline-Glutamate (GPE) Is Neuroprotective to Striatum in the Quinolinic Acid Lesion Animal Model of Huntington's Disease

By Alexi T.   Hughes P.E.   van Roon-Mom W.M.C.   Faull R.L.M.   Williams C.E.   Clark R.G.   Gluckman P.D.  

Experimental Neurology, Vol. 159, Iss. 1, 1999-09 ,pp. : 84-97

Elsevier

Access to resources Recommend Favorite